American Century Companies Inc Sage Therapeutics, Inc. Transaction History
American Century Companies Inc
- $160 Billion
- Q2 2024
A detailed history of American Century Companies Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 316,331 shares of SAGE stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
316,331
Previous 268,290
17.91%
Holding current value
$2.2 Million
Previous $5.03 Million
31.67%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SAGE
# of Institutions
217Shares Held
48.2MCall Options Held
854KPut Options Held
195K-
Vanguard Group Inc Valley Forge, PA6.42MShares$44.7 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$38.1 Million0.99% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$36.3 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$31.1 Million0.81% of portfolio
-
State Street Corp Boston, MA2.47MShares$17.2 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $414M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...